You are here: About the OfficeInternational cooperationInternational organisationsInternational research infrastructuresBiobanking and Biomolecular Research Infrastructure (BBMRI ERIC)
Biobanking and Biomolecular Research Infrastructure (BBMRI ERIC)
14 October 2021
Modified: 14 October 2021
Reading time: 2 minute(s)
BBMRI-ERICBBMRI-ERIC aims to promote the development of new, effective therapeutic treatments by aligning the needs and opportunities of researchers, the industry and patients in need of treatment through related biomedical research. As part of this, the organisation provides high-quality management services, advice on ethical, legal and social issues, and IT support to participants in research programmes. The coordinator of the BBMRI node in Hungary is Semmelweis University, and the University of Szeged, the University of Pécs and the Central Hospital of Southern Pest are among its participants.

Short name BBMRI-ERIC
Name Biobanking and Biomolecular Research Infrastructure - European Research Infrastructure Consortium
Official website
Year of foundation 2014
ESFRI project/landmark landmark
Headquarters Austria, Graz
Number of member countries 17
Participating countries Members: Austria, Belgium, Bulgaria, Czech Republic, Estonia, Finland, Germany, Greece, Hungary, Italy, Latvia, Malta, the Netherlands, Poland, Portugal, Norway, Sweden, United Kingdom,
observer: Cyprus, Lithuania, Switzerland, Turkey
Hungary’s accession 2021
Partner institutions in Hungary in 2021 Semmelweis University
University of Pécs,
University of Szeged,
Central Hospital of Southern Pest,
Richter Gedeon Zrt.
Public administration representative Orsolya Rigó-Ditzendy
National Research, Development and Innovation Office
Department for International Affairs
Nemzetközi Főosztály
1077 Budapest, Kéthly Anna tér 1.
Phone: +36 1 896 4004
Professional representative Mária Judit Molnár
Professor, Head of the Institute of Genomic Medicine and Rare Diseases, Faculty of Medicine, Semmelweis University
Membership payments 2021: EUR 21 496 (≈ 7,7 million)

Benefits of the membership for Hungary

  • It unifies the activities of the individual biobanks, creating a huge database for research.
  • Optimising diagnostic and therapeutic improvements, patient-centred care.
  • Support for biomedical, biological research.
  • The biobank research infrastructure is generating a national data asset that will form the basis for the development of many services in the future.
  • It catalyses domestic innovation, both in the pharmaceutical industry and in translational research, diagnostic services and health coaching.
Updated: 14 October 2021
Was this page helpful?